Belvedere Trading’s Rentokil RTO Stock Holding History

Belvedere Trading’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21	Closed	-$661	–	1175
2026 Q1	$661	Buy	+21	New	+$662	﹤0.01%	721

Other funds holding RTO

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GCM

Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Summitry LLC Foster City, California $3.04B AUM 17.05% 1-Year Est. Return

Belvedere Trading's RTO Position: Q2 2026 in Review

Belvedere Trading sold out of Rentokil (RTO) in Q2 2026, closing a stake of 21 shares — an estimated $661 sold.

Belvedere Trading first reported a position in RTO in Q1 2026 and held it in 1 quarter. The position peaked at $661 in Q1 2026. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

Belvedere Trading reported no remaining Rentokil position as of Q2 2026 after selling out during the quarter.
Belvedere Trading sold 21 Rentokil shares in Q2 2026, an estimated $661.
Belvedere Trading first reported a position in Rentokil in Q1 2026 and held it in 1 quarter.
Belvedere Trading's Rentokil position peaked at $661 in Q1 2026.
284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Belvedere Trading's 13F filing for Q2 2026, filed 31 Jul 2026.